Condensed Consolidated Statements of Operations - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
|
| Revenues: | ||||
| Revenue from services | $ 259,025 | $ 103,919 | $ 777,559 | $ 107,929 |
| Revenue from products | 20,569 | 20,765 | 63,275 | 59,066 |
| Revenue from transfer of intellectual property and other | 18,441 | 18,350 | 105,338 | 48,552 |
| Total revenues | 298,035 | 143,034 | 946,172 | 215,547 |
| Costs and expenses: | ||||
| Cost of service revenue | 138,554 | 56,670 | 417,121 | 61,434 |
| Cost of product revenue | 12,626 | 10,658 | 35,033 | 30,650 |
| Selling, general and administrative | 124,845 | 55,246 | 370,358 | 93,629 |
| Research and development | 24,424 | 18,937 | 83,594 | 74,010 |
| Contingent consideration | 3,093 | 1,636 | 15,604 | 6,471 |
| Amortization of intangible assets | 18,116 | 8,110 | 47,337 | 14,011 |
| Grant repayment | 0 | 0 | 0 | 25,889 |
| Total costs and expenses | 321,658 | 151,257 | 969,047 | 306,094 |
| Operating loss | (23,623) | (8,223) | (22,875) | (90,547) |
| Other income and (expense), net: | ||||
| Interest income | 163 | 13 | 341 | 27 |
| Interest expense | (2,018) | (2,745) | (6,022) | (6,296) |
| Fair value changes of derivative instruments, net | (5,701) | 32,244 | (5,889) | (34,100) |
| Other income (expense), net | (2,972) | 17,482 | 3,543 | 16,734 |
| Other income and (expense), net | (10,528) | 46,994 | (8,027) | (23,635) |
| Income (loss) before income taxes and investment losses | (34,151) | 38,771 | (30,902) | (114,182) |
| Income tax benefit | 19,988 | 92,978 | 24,626 | 87,218 |
| Income (loss) before investment losses | (14,163) | 131,749 | (6,276) | (26,964) |
| Loss from investments in investees | (814) | (3,502) | (5,147) | (6,067) |
| Net income (loss) | (14,977) | 128,247 | (11,423) | (33,031) |
| Less: Net loss attributable to noncontrolling interests | 0 | 0 | 0 | (1,400) |
| Net income (loss) attributable to common shareholders | $ (14,977) | $ 128,247 | $ (11,423) | $ (31,631) |
| Earnings (loss) per share: | ||||
| Earnings (loss) per share, basic (in dollars per share) | $ (0.03) | $ 0.26 | $ (0.02) | $ (0.07) |
| Earnings (loss) per share, diluted (in dollars per share) | $ (0.03) | $ 0.18 | $ (0.02) | $ (0.07) |
| Weighted average common shares outstanding, basic (in shares) | 552,229,266 | 500,562,254 | 548,550,641 | 469,931,486 |
| Weighted average common shares outstanding, diluted (in shares) | 552,229,266 | 515,512,850 | 548,550,641 | 469,931,486 |
| X | ||||||||||
- Definition Collaborative Arrangement, Grant Repayment Expense No definition available.
|
| X | ||||||||||
- Definition Gain (loss) from continuing operations before investment losses. No definition available.
|
| X | ||||||||||
- Definition Interest Expense, Nonoperating No definition available.
|
| X | ||||||||||
- Definition Interest Income, Nonoperating No definition available.
|
| X | ||||||||||
- Definition Revenue From Transfer Of Intellectual Property No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Total costs related to services rendered by an entity during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|